Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | EMB-06 |
| Trade Name | |
| Synonyms | EMB06|EMB 06 |
| Drug Descriptions |
EMB-06 is a bispecific antibody that targets B-cell maturation antigen (BCMA) expressed on tumor cells and CD3 on T-cells, potentially leading to activation of cytotoxic T-lymphocytes (CTL) and CTL-dependent killing of tumor cells expressing BCMA, and antitumor activity (NCI Drug Dictionary, Journal for ImmunoTherapy of Cancer 2023;11). |
| DrugClasses | CD3 Antibody 119 TNFRSF17 Antibody 22 |
| CAS Registry Number | NA |
| NCIT ID | C179632 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| EMB-06 | EMB-06 | 0 | 1 |